From Lab to Patient – The journey of a medicine assessed by EMA


EMA has published an infographic describing the journey of a medicine for human use authorised through EMA, from initial research to discussions on patient access to medicines across the EU.

This initiative aims to improve understanding of how EMA’s key procedures work. It explains in particular how EMA supports medicine development by providing scientific advice and how it assesses a medicine’s benefits and risks once it receives an application for marketing authorisation. All the steps involved in these processes, including the involvement of patients, healthcare professionals and other external experts, as well as the principles guiding the scientific discussions, are outlined in the infographic.

The infographic can be seen here.

Leave a Reply

Your email address will not be published. Required fields are marked *